Sudden cardiac arrest in patients with cancer in the general population: insights from the Paris-SDEC registry

被引:2
作者
Weizman, Orianne [1 ]
Eslami, Assie [2 ]
Bougouin, Wulfran [1 ,3 ]
Beganton, Frankie [1 ]
Lamhaut, Lionel [1 ]
Jost, Daniel [4 ]
Dumas, Florence [1 ]
Cariou, Alain [1 ,5 ]
Marijon, Eloi [1 ]
Jouven, Xavier [1 ]
Mirabel, Mariana [1 ,6 ]
机构
[1] INSERM, Paris, Ile De France, France
[2] AP HP, Paris, Ile De France, France
[3] Hop Prive Jacques Cartier, Ramsay Gen Sante, Med Intens Care Unit, Massy, France
[4] Paris Fire Brigade, Emergency Dept, Paris, Ile De France, France
[5] Univ Paris Cite, Fac Sante, Paris, France
[6] Inst Mutualiste Montsouris, F-75014 Paris, France
关键词
Epidemiology; Ventricular Fibrillation; ACUTE MYOCARDIAL-INFARCTION; OUTCOMES; MANAGEMENT; RISK;
D O I
10.1136/heartjnl-2024-324137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Data on the management of patients with cancer presenting with sudden cardiac arrest (SCA) are scarce. We aimed to assess the characteristics and outcomes of SCA according to cancer history. Methods Prospective, population-based registry including every out-of-hospital SCA in adults in Paris and its suburbs, between 2011 and 2019, with a specific focus on patients with cancer. Results Out of 4069 patients who had SCA admitted alive in hospital, 207 (5.1%) had current or past medical history of cancer. Patients with cancer were older (69.2 vs 59.3 years old, p<0.001), more often women (37.2% vs 28.0%, p=0.006) with more frequent underlying cardiovascular disease (41.1% vs 32.5%, p=0.01). SCA happened more often with a non-shockable rhythm (62.6% vs 43.1%, p<0.001) with no significant difference regarding witness presence and cardiopulmonary resuscitation (CPR) performed. Cardiac causes were less frequent among patients with cancer (mostly acute coronary syndromes, 25.5% vs 46.8%, p<0.001) and had more respiratory causes (pulmonary embolism and hypoxaemia in 34.2% vs 10.8%, p<0.001). Still, no difference regarding in-hospital survival was found after SCA in patients with cancer versus other patients (26.2% vs 29.8%, respectively, p=0.27). Public location, CPR by witness and shockable rhythm were independent predictors of in-hospital survival after SCA in the cancer group. Conclusions One in 20 SCA occurs in patients with a history of cancer, yet with fewer cardiac causes than in patients who are cancer-free. Still, in-hospital outcomes remain similar even in patients with known cancer. Cancer history should therefore not compromise the initiation of resuscitation in the context of SCA.
引用
收藏
页码:1022 / 1029
页数:8
相关论文
共 30 条
  • [1] Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA
    Bharadwaj, Aditya
    Potts, Jessica
    Mohamed, Mohamed O.
    Parwani, Purvi
    Swamy, Pooja
    Lopez-Mattei, Juan C.
    Rashid, Muhammad
    Kwok, Chun Shing
    Fischman, David L.
    Vassiliou, Vassilios S.
    Freeman, Philip
    Michos, Erin D.
    Mamas, Mamas A.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (23) : 2183 - +
  • [2] Pulmonary embolism related sudden cardiac arrest admitted alive at hospital: Management and outcomes
    Bougouin, Wulfran
    Marijon, Eloi
    Planquette, Benjamin
    Karam, Nicole
    Dumas, Florence
    Celermajer, David S.
    Jost, Daniel
    Lamhaut, Lionel
    Beganton, Frankie
    Cariou, Alain
    Meyer, Guy
    Jouven, Xavier
    [J]. RESUSCITATION, 2017, 115 : 135 - 140
  • [3] Factors Associated With Pulmonary Embolism-Related Sudden Cardiac Arrest
    Bougouin, Wulfran
    Marijon, Eloi
    Planquette, Benjamin
    Karam, Nicole
    Dumas, Florence
    Celermajer, David S.
    Jost, Daniel
    Lamhaut, Lionel
    Beganton, Frankie
    Cariou, Alain
    Meyer, Guy
    Jouven, Xavier
    [J]. CIRCULATION, 2016, 134 (25) : 2125 - 2127
  • [4] Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
    Drobni, Zsofia D.
    Alvi, Raza M.
    Taron, Jana
    Zafar, Amna
    Murphy, Sean P.
    Rambarat, Paula K.
    Mosarla, Rayma C.
    Lee, Charlotte
    Zlotoff, Daniel A.
    Raghu, Vineet K.
    Hartmann, Sarah E.
    Gilman, Hannah K.
    Gong, Jingyi
    Zubiri, Leyre
    Sullivan, Ryan J.
    Reynolds, Kerry L.
    Mayrhofer, Thomas
    Zhang, Lili
    Hoffmann, Udo
    Neilan, Tomas G.
    [J]. CIRCULATION, 2020, 142 (24) : 2299 - 2311
  • [5] Pulmonary embolism at autopsy in cancer patients
    Gimbel, Inge A.
    Mulder, Frits I.
    Bosch, Floris T. M.
    Freund, Jan Erik
    Guman, Noori
    van Es, Nick
    Kamphuisen, Pieter W.
    Buller, Harry R.
    Middeldorp, Saskia
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (05) : 1228 - 1235
  • [6] The Frequency and Severity of Cardiovascular Toxicity From Targeted Therapy in Advanced Renal Cell Carcinoma Patients
    Hall, Philip S.
    Harshman, Lauren C.
    Srinivas, Sandy
    Witteles, Ronald M.
    [J]. JACC-HEART FAILURE, 2013, 1 (01) : 72 - 78
  • [7] Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study
    Haugnes, Hege S.
    Wethal, Torgeir
    Aass, Nina
    Dahl, Olav
    Klepp, Olbjorn
    Langberg, Carl W.
    Wilsgaard, Tom
    Bremnes, Roy M.
    Fossa, Sophie D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) : 4649 - 4657
  • [8] Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
    Herrmann, Joerg
    [J]. NATURE REVIEWS CARDIOLOGY, 2020, 17 (08) : 474 - 502
  • [9] Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
    Kocarnik, Jonathan M.
    Compton, Kelly
    Dean, Frances E.
    Fu, Weijia
    Gaw, Brian L.
    Harvey, James D.
    Henrikson, Hannah Jacqueline
    Lu, Dan
    Pennini, Alyssa
    Xu, Rixing
    Ababneh, Emad
    Abbasi-Kangevari, Mohsen
    Abbastabar, Hedayat
    Abd-Elsalam, Sherief M.
    Abdoli, Amir
    Abedi, Aidin
    Abidi, Hassan
    Abolhassani, Hassan
    Adedeji, Isaac Akinkunmi
    Adnani, Qorinah Estiningtyas Sakilah
    Advani, Shailesh M.
    Afzal, Muhammad Sohail
    Aghaali, Mohammad
    Ahinkorah, Bright Opoku
    Ahmad, Sajjad
    Ahmad, Tauseef
    Ahmadi, Ali
    Ahmadi, Sepideh
    Rashid, Tarik Ahmed
    Salih, Yusra Ahmed
    Akalu, Gizachew Taddesse
    Aklilu, Addis
    Akram, Tayyaba
    Akunna, Chisom Joyqueenet
    Al Hamad, Hanadi
    Alahdab, Fares
    Al-Aly, Ziyad
    Ali, Saqib
    Alimohamadi, Yousef
    Alipour, Vahid
    Aljunid, Syed Mohamed
    Alkhayyat, Motasem
    Almasi-Hashiani, Amir
    Almasri, Nihad A.
    Al-Maweri, Sadeq Ali Ali
    Almustanyir, Sami
    Alonso, Nivaldo
    Alvis-Guzman, Nelson
    Amu, Hubert
    Anbesu, Etsay Woldu
    [J]. JAMA ONCOLOGY, 2022, 8 (03) : 420 - 444
  • [10] Cardio-Oncology An Update on Cardiotoxicity of Cancer-Related Treatment
    Lenneman, Carrie G.
    Sawyer, Douglas B.
    [J]. CIRCULATION RESEARCH, 2016, 118 (06) : 1008 - 1020